These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 4397371)

  • 1. [Experimental study on the pharmacology of a beta-adrenolytic agent: H 56-28 alprenolol. Studies with a special regard to the cardiovascular system, tracheal, gastric, intestinal, splenic and deferent muscles].
    Marmo E
    Clin Ter; 1971 Jan; 56(2):121-76. PubMed ID: 4397371
    [No Abstract]   [Full Text] [Related]  

  • 2. [Review of literature and experimental contribution on KO 592, a drug with beta-adrenolytic activity. I].
    Marmo E; Caputi AP; Saini RK
    Clin Ter; 1972 Jul; 62(1):11-51. PubMed ID: 4403671
    [No Abstract]   [Full Text] [Related]  

  • 3. [Beta-adrenalytics and gastric, intestinal and uterine musculature. Experimental research with pronethalal, propranolol, Kö 592, MJ 1998, MJ 1999 and iproveratril].
    Marmo E; Coscia L; Magliulo S
    Farmaco Sci; 1967 Sep; 22(9):735-68. PubMed ID: 4383230
    [No Abstract]   [Full Text] [Related]  

  • 4. [Review of literature and experimental contribution on KO 592 a drug with beta-adrenolytic activity. II].
    Marmo E; Caputi AP; Saini RK
    Clin Ter; 1972 Jul; 62(2):117-63. PubMed ID: 4403714
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cardiovascular effects of alprenolol(beta-blockade) under halothane anesthesia].
    Yoshida T; Kubota M; Tamura A; Suzuki K; Furukawa Y
    Masui; 1969 Nov; 18(11):1071-8. PubMed ID: 4391283
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of some beta adrenergic blocking agents on the central and peripheral actions of tremorine and oxotremorine.
    Leslie GB; Hayman DG; Ireson JD; Smith S
    Arch Int Pharmacodyn Ther; 1972 May; 197(1):108-11. PubMed ID: 4402325
    [No Abstract]   [Full Text] [Related]  

  • 7. Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT; Gluckman MI
    J Pharmacol Exp Ther; 1971 Feb; 176(2):339-49. PubMed ID: 4398186
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental analysis of the cardiovascular effects of acebutolol, a drug with beta-adrenolytic activity].
    Marmo E; Rossi F; Lampa E; Chieppa S; Apolito A; Del Vecchio F
    Arch Sci Med (Torino); 1978; 135(1):57-78. PubMed ID: 25058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-adrenergic blocker, 2-(2-hydroxy-3-tert-butylaminopropoxy) chlorobenzene hydrochloride (D-69-12).
    Takagi K; Takayanagi I; Kaziwara Y; Hiramatsu Y; Izumi A
    Jpn J Pharmacol; 1970 Dec; 20(4):504-8. PubMed ID: 4395620
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of terbutalin on the cardiovascular system and tracheo-bronchial, gastrointestinal, splenic and differential musculature. Experimental comparative research with isoprenaline, metaproterenol, soterenol, salbutamol, chlorprenaline, isoxysuprin and quinterenol].
    Marmo E
    Farmaco Prat; 1971 Aug; 26(8):426-97. PubMed ID: 4398396
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative studies on the question of differentiation of adrenergic beta-receptors].
    Mentz P; Bayer B; Wartner U; Förster W
    Arch Int Pharmacodyn Ther; 1970 Sep; 187(1):23-9. PubMed ID: 4394699
    [No Abstract]   [Full Text] [Related]  

  • 12. Reflex and other cardiovascular changes in anesthetized dogs after beta adrenergic blockade.
    Robson RD; Lewis D; Thompson S
    J Pharmacol Exp Ther; 1971 Mar; 176(3):662-71. PubMed ID: 4398745
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of a few -sympatholytics (propranolol, C.39'089-Ba, H56-28 and Ko 592) on serum cholinesterase of rats].
    Marmo E
    Jpn J Pharmacol; 1971 Jun; 21(3):421-3. PubMed ID: 4397670
    [No Abstract]   [Full Text] [Related]  

  • 14. Steric aspects of adrenergic drugs. 8. Optical isomers of beta adrenergic receptor antagonists.
    Patil PN
    J Pharmacol Exp Ther; 1968 Apr; 160(2):308-14. PubMed ID: 4384787
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental studies of the specificity and aspecificity of a beta-adrenolytic agent, bunitrolol (Kö 1366)].
    Marmo E; Lampa E; Rossi F; Caputi AP; Chieppa S; Vacca C; Giordano L; Pedone P
    Arch Sci Med (Torino); 1978; 135(1):15-56. PubMed ID: 25057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenergic receptor blocking properties of three allyl-substituted phenoxypropanolamines.
    Ablad B; Brogård M; Carlsson E; Ek L
    Eur J Pharmacol; 1970; 13(1):59-64. PubMed ID: 4395676
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of a beta-adrenergic block with pronethalol, propranolol, hydrobutamine, C.39'089-Ba and H 56-28 on the electrocardiographic modifications of NaCl,MgCl 2 and KCl in rat].
    Marmo E; Caputi A; Fucci G; Imperatore A
    Folia Cardiol; 1969; 28():83-91. PubMed ID: 4398000
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prolonging hexabarbiturate anesthesia by beta adrenolytic drugs].
    Wagner J; Kierfeld E
    Arzneimittelforschung; 1971 Mar; 21(3):414-6. PubMed ID: 4396292
    [No Abstract]   [Full Text] [Related]  

  • 19. [The stimulating effect of hexoprenaline on various sympathetic beta-receptors].
    Stormann H; Turnheim K
    Arzneimittelforschung; 1973 Jan; 23(1):30-8. PubMed ID: 4146792
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular effects of equi-antiarrhythmic doses of alprenolol (a beta-adrenergic receptor antagonist) diphenylhydantoin and procainamide.
    Proctor JD; Allen FJ; Wasserman AJ
    Arch Int Pharmacodyn Ther; 1971 Apr; 190(2):354-67. PubMed ID: 4396926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.